Novo Nordisk cut its 2025 guidance and outgoing CEO blames the compounding market for it.
Novo Nordisk outgoing CEO blames compounded GLP-1s for decline in 2025 outlook
July 29, 2025
You may also like
Indices by TradingView
Nvidia’s $4 trillion moment came with a quiet warning sign
December 24, 2025
Nvidia to buy AI chip startup Groq for about $20 billion, CNBC reports
December 24, 2025
Categories
Indices by TradingView


